CRMC Fall 2026 Learning Session

Get Ready for the CRMC Fall 2026 Learning Session!

CRMC Fall 2026 Learning Session

Learning Objectives:

At the completion of this activity, participants should be able to:

1. Describe current mental health and substance use disorder challenges affecting community pharmacy practice and their impact on patient access, medication use, and health outcomes.

2. Apply evidence-based strategies for managing psychotropic medications, including off-label use, dosing optimization, long-acting injectable antipsychotics, and documentation within current regulatory and legal frameworks.

3. Evaluate current evidence and best practices for the management of substance use disorders, including the use of buprenorphine, approaches to stimulant use disorder, and emerging therapies.

4. Identify opportunities to expand pharmacist-provided behavioral health services through collaborative care models, community partnerships, and implementation of long-acting injectable medication services.

5. Incorporate quality improvement strategies, including high-risk medication management and payer initiatives such as Medicare STAR measures, to enhance behavioral health services in community pharmacy practice.

6. Develop an individualized action plan to implement at least one evidence-based strategy that improves access to or quality of mental health care within their practice setting.

Find our full session schedule below: